Physician profile
John Herrington Kosko
NPI 1295937928
$40,460.59
in general payments reported to CMS, 2019-2025
21 companies · $12K in 2025
The $12K reported for 2025 was more than what 81% of Foot and Ankle Surgery providers received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,888 · 2020: $1,286 · 2021: $4,581 · 2022: $9,666 · 2023: $6,496 · 2024: $3,210 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $12K · Travel and Lodging: $6,946 · Food and Beverage: $2,729.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $12,364.57 |
| Travel and Lodging | $6,946.28 |
| Food and Beverage | $2,729.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $12,406.00 | 2023-2025 | Allograft Tissue, Alloaid, Quantum |
| In2bones USA, LLC | $11,446.37 | 2020-2022 | |
| Paragon 28, INC. | $6,573.27 | 2019-2025 | Portfolio, Apex 3d, Grappler |
| Alon Medical Technology | $2,847.37 | 2021-2025 | |
| Wright Medical Technology, INC. | $2,742.10 | 2019-2020 | |
| Arthrex, INC. | $1,861.72 | 2021-2025 | Distal Extremities Implants Soft Tissue Ib Ligament Augmentation |
| Stryker Corporation | $1,116.45 | 2019-2024 | Anchorage, Claw II |
| Depuy Synthes Sales INC. | $321.21 | 2020-2025 | Motoband, Na |
| Abbott Laboratories | $295.81 | 2020-2023 | Eterna |
| Coastal Medical Technologies LLC | $165.24 | 2023 | |
| Triad Life Sciences INC. | $138.78 | 2022 | |
| Boston Scientific Corporation | $93.59 | 2019-2021 | |
| Medshape, INC. | $89.51 | 2025 | Dynanail |
| Vertex Pharmaceuticals Incorporated | $80.05 | 2024-2025 | |
| Organogenesis INC. | $73.04 | 2025 | Cygnus Dual, Via Matrix, Simplimax |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kuros Biosciences USA, INC | $68.73 | 2025 | Magnetos |
| Zimmer Biomet Holdings, INC. | $39.35 | 2024 | |
| Treace Medical Concepts, INC. | $35.88 | 2023-2024 | |
| Bioventus LLC | $29.55 | 2023-2024 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Medela LLC | $20.63 | 2021-2022 | |
| Kowa Pharmaceuticals America, INC. | $15.94 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Kosko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.